Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 22;107(8):e3515–e3525. doi: 10.1210/clinem/dgac166

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Figure 2. — Measures of luteinizing hormone (LH) pulsatility profile at visits 1 and 2 (n = 11). Pulse frequency, mean LH, and interpulse interval (IPI) were calculated across the time frame of kisspeptin administration (hour 1-hour 11). LH pulse amplitude for visit 2 includes value from response to first kisspeptin bolus only. One participant experienced only one pulse during visit 1. For this individual, hour 11 was used as the equivalent to the nadir of subsequent pulse for IPI calculations. A, pulse frequency; B, LH pulse amplitude; C, mean LH levels; and D, IPI. Statistically significant P values are included in the figure.